| Dr Richard L Christiana, | |
|
210 9th St Se, Rochester, MN 55904-6425 | |
| (507) 288-3443 | |
| Not Available |
| Full Name | Dr Richard L Christiana |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine - Occupational Medicine |
| Location | 210 9th St Se, Rochester, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285688077 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083X0100X | Preventive Medicine - Occupational Medicine | 018338 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard L Christiana, 210 9th St Se, Rochester, MN 55904-6425 Ph: (507) 288-3443 | Dr Richard L Christiana, 210 9th St Se, Rochester, MN 55904-6425 Ph: (507) 288-3443 |
News Archive
A team of researchers from Germany, Taiwan, and the United States has identified and characterized a new hidden gene in SARS-CoV-2 that is also present in Guangxi pangolin coronaviruses – though, curiously, absent in closely related pangolin and bat coronaviruses.
"The incidence of type l diabetes, one of the most prevalent chronic diseases in children, has increased worldwide," write Valma Harjutsalo, Ph.D., of the Diabetes Prevention Unit, Helsinki, Finland, and colleagues, who conducted a study to examine the incidence rates of T1D between 2006 and 2011 in Finnish children younger than 15 years as well as the 32-year trend (1980-2011).
Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today positive results in a Phase IIa clinical trial of plecanatide (SP-304) in patients with chronic constipation. Oral plecanatide given once daily, over 14 consecutive days, at doses of 0.3, 1.0, 3.0 and 9.0 mg gave improved bowel function in patients with chronic constipation.
KYTHERA Biopharmaceuticals, Inc., a privately-held biotechnology company focused on the development and commercialization of prescription products in aesthetic medicine, presented results from a long-term follow up study assessing persistence of efficacy and post-treatment safety of ATX-101, a first-in-class, injectable drug that is under investigation for the reduction of submental fat.
› Verified 6 days ago
Laura Elizabeth Breeher, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
James R Hickman, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Fred Thomas Nobrega, MD Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 1118 Skyline Dr Sw, Rochester, MN 55902 Phone: 507-289-8402 | |
Hamid Rehman, MBBS Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Akira Fujiyoshi, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Marilynn Walliser Olney, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 4440 48th St Ne, Rochester, MN 55906 Phone: 507-285-9678 | |
Cindy A Kermott, M.D., M.P.H. Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |